Fostamatinib for Hospitalized Adults With COVID-19
Clinical trial NCT04579393 · COMPLETED
Trial details
- NCT number
- NCT04579393
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-08
- Primary completion
- 2021-03-30
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.